HDC Code Application Update Go back »

2022-03-04 | All chapters

HDC Code Application Update

 

By 25th February 2022, Chinese embassies in nine European countries (Austria, Finland, Germany, Luxembourg, the Netherlands, Norway, Poland, Romania and Switzerland*) have updated their Health Declaration Certificate code application requirements, stating that people fully inoculated with COVID-19 vaccines (whether Chinese or non-Chinese vaccines) who are travelling to China need to take two PCR tests within 48 hours before boarding – instead of the previously required one PCR test and one IgM test. For people who are not fully inoculated with COVID-19 vaccines, the rule of one PCR test and one IgM test still applies.

*The new testing requirements for personnel from Switzerland to China will take effect from 1st April 2022, and the transition period will be from 20th March to 31st March.

For the Czech Republic, Hungary and the United Kingdom (UK), people fully inoculated with inactivated vaccines who are travelling from those countries to China must take two PCR tests instead of the previously required one PCR test and one IgM test. People inoculated with non-inactivated vaccines still need to take one PCR test and one IgM test.

Starting from 1st February 2022, all persons transiting from a third country to Charles de Gaulle Airport in France need to take two PCR tests at the airport testing agency – instead of one IgM test. If the two PCR tests are negative, they can apply for a health code to go to China. The relevant policies for personnel flying directly from France to China remain unchanged for the time being, and the "PCR + IgM" test is still applicable.

The European Chamber has collected relevant information from the websites of the Chinese embassies in several European countries. Detailed requirements may vary from country to country. Please refer to each country’s regulation (see links below) in individual cases.

 

European Member States

AUSTRIA

关于调整健康码/健康状况声明书办理要求的通知, 2022-01-17

从2022年1月24日起(含当日),已接种疫苗人员,无论接种灭活疫苗(国药、科兴),还是非灭活疫苗(莫德纳、辉瑞、强生等),相关人员在完成接种满14天以后(加强针无时间间隔要求),均需在赴华航班前2日在我馆指定的任意两家不同检测机构完成2次PCR核酸检测,两次检测须间隔12小时以上,无需做IgM抗体检测。

 

CZECH REPUBLIC

Different tests for people inoculated with inactivated and non-inactivated vaccines.

自捷克始发赴华人员申领健康码/健康状况声明书有关要求汇编(最新版), 2021年12月28日

已接种灭活疫苗人员(例如,国药疫苗、科兴疫苗)需在两家不同检测机构分别做一次核酸检测,无需做血清IgM抗体检测。

已接种非灭活疫苗人员(例如,辉瑞、莫德纳、强生、阿斯利康疫苗)原则上需做核酸检测和静脉采血的针对N蛋白的IgM抗体检测(简称“静脉血N蛋白IgM抗体检测”)。

 

FINLAND

Supplementary Notice for Travellers Fully Inoculated with COVID-19 Vaccines, 2022-01-04

Starting from 10th January 2022, people fully inoculated with COVID-19 vaccines who are travelling from Finland to China need to take two PCR tests, instead of the previously required one PCR test and one IgM test.

 

FRANCE

关于调整自第三国来法中转赴华人员检测政策的通知, 2022-01-19

自2022年2月1日开始,所有自第三国来法国戴高乐机场转机赴华人员,均须在机场检测机构进行两次核酸检测,取消血清抗体检测。两次核酸检测均为阴性人员,可申请健康码赴华。自法国直飞赴华人员相关政策暂时不变,仍适用“核酸+抗体”检测。

 

GERMANY

赴华人员登机前新冠肺炎检测要求, 2022-02-17

自2022年2月21日起,已接种人员在赴华航班起飞前2天(48小时)内应在同一领区内的两个不同的检测机构各进行1次核酸检测(共计2次核酸,以下简称“双核酸”),无需再进行血清抗体IgM检测。

 

GREECE

Notice on Health Declaration Code Application Requirement for Passengers Traveling to China, 2021-12-31

For passengers who are inoculated with inactivated COVID-19 vaccines (for example, China's SINOPHARM and SINOVAC vaccines, etc.), a PCR test should be conducted at two different designated clinics at intervals of 24 hours, and within 48 hours before boarding.

Passengers who are vaccinated with non-inactivated COVID-19 vaccines (for example, Pfizer, Moderna, Johnson&Johnson and AstraZeneca vaccines, etc.), please conduct both a PCR test and an anti-N protein test.

 

HUNGARY

Different tests for people inoculated with inactivated and non-inactivated vaccines.

驻匈牙利使馆关于调整已接种人员赴华行前双检测要求的重要通知, 2022-01-06

自2022年1月10日起(过渡期一周),所有自匈出发搭乘航班赴华人员,应于赴中转地48小时前在中国驻匈牙利使馆指定的检测机构完成以下新冠病毒检测:

已完成疫苗接种人员(需按程序完成两次剂且满14天)

(一)如已接种国药、科兴等灭活疫苗:须在48小时内进行两次核酸RT-PCR检测(两次核酸检测须在MikroMikoMed Kft.及另外一家我馆指定机构完成),并取得“双核酸”检测阴性证明,无需再进行血清IgM抗体检测;

(二)如接种非灭活疫苗:(辉瑞、莫德纳、阿斯利康、强生、卫星V),则仅需进行一次核酸RT-PCR检测及一次N蛋白抗体检测,凭核酸和N蛋白检测“双阴”证明,申领健康码。

 

LUXEMBOURG

关于调整从卢森堡出发赴华远端检测规定的通知(2022年1月版), 2022-01-04

自2022年1月8日起,以“双核酸检测”替代“核酸+血清IgM抗体检测”(须用鼻咽拭子采样进行RT-PCR检测,不接受快速检测结果)。“双核酸检测”结果为双阴性的,可申请健康码。

 

THE NETHERLANDS

关于更新健康码/健康状况声明书二维码受理要求的通知, 2022-01-08

自2022年1月17日起(以航班起飞日期为准),驻荷兰使馆将实施接种疫苗人员登机前双核酸检测和未接种疫苗人员登机前核酸、血清IgM抗体双检测措施。

 

NORWAY

关于搭乘航班赴华人员须凭新冠病毒核酸检测及血清抗体检测双阴性证明乘机的通知(2021年12月更新), 2021-12-25

完成接种疫苗所需全部针剂数量满14天人员视为接种人员,应接种两针但只接种一针的不视为接种人员。完全接种人员须在登机前48小时内在不同检测机构完成2次核酸检测(采样时间间隔24小时以上),无需进行血清IgM抗体检测。

 

POLAND

关于调整搭乘赴华航班人员乘机前新冠病毒检测要求的通知, 2021-12-30

自2022年1月10日(含)起,所有自波兰搭乘航班赴华人员,应于登机前48小时内在中国驻波兰使馆指定的检测机构完成以下新冠病毒检测,已完成疫苗接种人员(按程序完成全部接种次剂且满14天),须进行两次核酸RT-PCR检测(两次核酸检测须在不同指定检测机构完成),并取得“双核酸”检测阴性证明,无需再进行血清IgM抗体检测。

 

ROMANIA

关于搭乘航班赴华人员须凭“核酸+IgM双检测” 或“双核酸检测”证明申领健康码的通知, 2022-01-10

自2022年1月17日(含当天)起,从罗马尼亚出发、搭乘航班赴华的中、外籍乘客,须凭新冠病毒核酸检测(RT-PCR test)和血清特异性IgM抗体检测(serum IgM antibody test)【“核酸+IgM双检测”,针对未接种或未完整接种疫苗人员】证明,或两次新冠病毒核酸检测【“双核酸检测”,针对已完整接种疫苗人员】证明。

 

Other European states

SWITZERLAND

关于调整自瑞士赴华人员登机前新冠病毒检测要求的通知, 2022-02-25

自2022年4月1日(含)起,对自瑞士赴华人员登机前新冠病毒检测要求进行调整,3月20日-3月31日为过渡期。已完成疫苗接种人员:须在登机前48小时内,在同一领区驻瑞士使领馆指定检测机构进行两次核酸RT-PCR检测(简称“双核酸”),两次核酸检测无时间间隔要求,须在不同的指定检测机构完成,并取得“双核酸”检测阴性证明,无需再进行血清IgM抗体检测。申请“健康码”时,请填写第一次核酸检测机构名称。

 

UK

Different tests for people inoculated with inactivated and non-inactivated vaccines.

Supplementary Notice for Travellers Fully Inoculated with Inactivated Vaccines, 2021-12-31

Starting from 6th January 2022, people fully inoculated with inactivated vaccines who are travelling from the UK to China need to take two PCR tests instead of the previously required one PCR test and one IgM test. 

 

Disclaimer:

  1. It is provided for informational purposes only. The European Chamber does not accept responsibility for any omission, error or inaccuracy in this document or any action taken in reliance thereon.
  2. This is based on information publicly available on the websites of Chinese embassies in Europe. Policies are subject to frequent changes. All details need to be verified in each individual case.
  3. Detailed requirements may vary from country to country. Please refer to each country’s regulation in individual cases.